top of page

Summaries of scientific recommendations on classification of advanced-therapy medicinal products

The European Medicines Agency's Committee for Advanced Therapies delivers scientific recommendations on whether a medicine can be classified as an advanced-therapy medicinal product (ATMP). The Agency publishes the outcomes of these assessments in the format of summary reports.

Click on this link for more information.


Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page